Found: 30
Select item for more details and to access through your institution.
Delayed transcapillary transport of insulin to muscle interstitial fluid in obese subjects.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Delayed transcapillary delivery of insulin to muscle interstitial fluid after oral glucose load in obese subjects.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Muscle glucose uptake is effectively activated by ischemia in type 2 diabetic subjects.
- Published in:
- 2000
- By:
- Publication type:
- journal article
271-OR: ADA Presidents' Select Abstract: Effect of Dapagliflozin on the Incidence of Diabetes: A Prespecified Exploratory Analysis from DAPA-HF.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-271-OR
- By:
- Publication type:
- Article
1112-P: Does Background T2D Therapy Modify the Benefits of Dapagliflozin in Heart Failure? Analysis of the DAPA-HF Trial.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1112-P
- By:
- Publication type:
- Article
Delayed transcapillary delivery of insulin to muscle interstitial fluid after oral glucose load in obese subjects.
- Published in:
- 2005
- By:
- Publication type:
- corrected article
Retraction.
- Published in:
- 2005
- By:
- Publication type:
- Erratum
Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical Trials.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 3, p. 587, doi. 10.1007/s13300-017-0261-8
- By:
- Publication type:
- Article
Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1856, doi. 10.1002/ejhf.2649
- By:
- Publication type:
- Article
Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 6, p. 1066, doi. 10.1002/ejhf.2433
- By:
- Publication type:
- Article
Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 3, p. 513, doi. 10.1002/ejhf.2381
- By:
- Publication type:
- Article
Effect of dapagliflozin on anaemia in DAPA‐HF.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 4, p. 617, doi. 10.1002/ejhf.2132
- By:
- Publication type:
- Article
Efficacy and safety of dapagliflozin according to aetiology in heart failure with reduced ejection fraction: insights from the DAPA‐HF trial.
- Published in:
- European Journal of Heart Failure, 2021, v. 23, n. 4, p. 601, doi. 10.1002/ejhf.2124
- By:
- Publication type:
- Article
Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA-HF.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and safety of sodium-glucose co-transporter 2 inhibition according to left ventricular ejection fraction in DAPA-HF.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Dapagliflozin and atrial fibrillation in heart failure with reduced ejection fraction: insights from DAPA-HF.
- Published in:
- European Journal of Heart Failure. Supplements, 2022, v. 24, n. 3, p. 513, doi. 10.1002/ejhf.2381
- By:
- Publication type:
- Article
Effects of Intrabrachial Metacholine Infusion on Muscle Capillary Recruitment and Forearm Glucose Uptake during Physiological Hyperinsulinemia in Obese, Insulin-Resistant Individuals.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2008, v. 93, n. 7, p. 2764, doi. 10.1210/jc.2007-2737
- By:
- Publication type:
- Article
Decreased Muscle Capillary Permeability Surface Area in Type 2 Diabetic Subjects.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 2, p. 1078, doi. 10.1210/jc.2004-0947
- By:
- Publication type:
- Article
Direct Measurements of the Permeability Surface Area for Insulin and Glucose in Human Skeletal Muscle.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 10, p. 4559, doi. 10.1210/jc.2003-030434
- By:
- Publication type:
- Article
Measurements of Interstitial Muscle Glycerol in Normal and Insulin-Resistant Subjects.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2002, v. 87, n. 5, p. 2206, doi. 10.1210/jc.87.5.2206
- By:
- Publication type:
- Article
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction : A Post Hoc Analysis of the DAPA-HF Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction: A Post Hoc Analysis of the DAPA-HF Trial.
- Published in:
- Annals of Internal Medicine, 2022, v. 175, n. 6, p. 820, doi. 10.7326/M21-4776
- By:
- Publication type:
- Article
Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF.
- Published in:
- European Heart Journal, 2021, v. 42, n. 36, p. 3727, doi. 10.1093/eurheartj/ehab560
- By:
- Publication type:
- Article
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF).
- Published in:
- European Heart Journal, 2020, v. 41, n. 36, p. 3402, doi. 10.1093/eurheartj/ehaa496
- By:
- Publication type:
- Article
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy.
- Published in:
- European Heart Journal, 2020, v. 41, n. 25, p. 2379, doi. 10.1093/eurheartj/ehaa183
- By:
- Publication type:
- Article
Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article